• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

U.K. study strengthens case for breast MR screening

Article

A multicenter study published online May 16 by The Lancet has shown that a combination of MRI and mammography offers the best means of detecting breast cancer in women with a high genetic risk for the disease.

A multicenter study published online May 16 by The Lancet has shown that a combination of MRI and mammography offers the best means of detecting breast cancer in women with a high genetic risk for the disease.

The investigators found MRI significantly more sensitive than mammography (77% versus 40%) in detecting breast cancers across the group of 649 women. Combining the results increased the sensitivity to 94%. MRI proved especially effective in BRCA1 mutation carriers, in whom it detected all tumors. Both techniques were needed to spot all cancers in women carrying BRCA2 mutations.

Commenting on the study, Dr. Ellen Warner, a medical oncologist at Toronto-Sunnybrook Regional Cancer Centre, said that mammography may one day be abandoned for high-risk women.

Recent Videos
Radiology Study Finds Increasing Rates of Non-Physician Practitioner Image Interpretation in Office Settings
Assessing a Landmark Change in CMS Reimbursement for Diagnostic Radiopharmaceuticals
Addressing the Early Impact of National Breast Density Notification for Mammography Reports
2 KOLs are featured in this series.
2 KOLs are featured in this series.
Can 18F-Floutufolastat Bolster Detection of PCa Recurrence in Patients with Low PSA Levels After Radical Prostatectomy?
2 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
Related Content
© 2024 MJH Life Sciences

All rights reserved.